CHMP recommends Lyfnua as a treatment for refractory or unexplained chronic cough – Merck Inc
Merck Inc., known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA)… read more.